Diagnosis of MGRS in Patients With Paraproteinemias: Clinical, Anatomopathological and Pathophysiological Study (MGRS-CAPS)
Diagnosis of Monoclonal Gammopathy of Renal Significance in Patients With Paraproteinemias
Sponsor: Academia Nacional de Medicina
Listed as NCT03629561, this observational or N/A phase trial focuses on Monoclonal Gammopathy of Renal Significance and remains ongoing. Sponsored by Academia Nacional de Medicina, it has been updated 10 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Oct 2021 — Dec 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Mar 2019 — Nov 2020 [monthly]
Recruiting
-
Feb 2019 — Mar 2019 [monthly]
Recruiting
-
Jan 2019 — Feb 2019 [monthly]
Recruiting
-
Sep 2018 — Jan 2019 [monthly]
Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Academia Nacional de Medicina
For direct contact, visit the study record on ClinicalTrials.gov .